All In MedTech

FDA Clearance Tracker · P210018

Et Control

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Mar 17, 2022 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Mar 17, 2022

Approved

Time to decision

318 days

Received May 3, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P210018
Device name
Et Control
Applicant location
Madison, WI
Received
May 3, 2021
Decided
Mar 17, 2022
Decision
Approved

Device type

Device class
Class III

Every decision under product code QSF

FDA's approval statement

As written in FDA's record.

Approval for Et Control indicated for use with the Datex-Ohmeda Aisys CS2 anesthesia system to support clinicians in maintaining the targeted end tidal oxygen and end tidal anesthetic agent concentrations that the clinician sets during an anesthetic procedure, by making multiple, limited adjustments to the fresh gas composition and total flow. The Et Control feature is indicated for patients, 18 years of age and older.The Aisys CS2 anesthesia system and the Et Control feature are intended for prescription use only.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code QSF (Software option for anesthesia gas machine to achieve and maintain targeted end tidal oxygen and anesthetic agents).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Datex-Ohmeda, Inc., A General Electric Company

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.